IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
59 hedge funds and large institutions have $19.6M invested in Insight Molecular Diagnostics Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 13 closing their positions.
Holders
59
Holders Change
-6
Holders Change %
-9.23%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
10
Reduced
20
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$455K |
2 |
AIC
2
AWM Investment Company
New York
|
$2.33M |
3 |
PM
3
Penbrook Management
New York
|
$66.6K |
4 |
SSA
4
Schonfeld Strategic Advisors
New York
|
$136K |
5 |
5
Goldman Sachs
New York
|
$19.8K |